SLIDE 1
Results of Intellectual Property and Technology Transfer Sub-group Survey
May 14, 2018
Survey Respondents: Research Funding Entity? Or Research Performing Entity?
40
respondents
Technology Transfer Sub-group Survey May 14, 2018 Survey - - PowerPoint PPT Presentation
Technology Transfer Sub-group Survey May 14, 2018 Survey - - PowerPoint PPT Presentation
Results of Intellectual Property and Technology Transfer Sub-group Survey May 14, 2018 Survey Respondents: Research Funding Entity? Or Research Performing Entity? 40 respondents Scope of definition of IP (e.g., Which kinds of IP are going to
SLIDE 2
SLIDE 3
Scope of definition of IP (e.g., Which kinds of IP are going to be considered and affected by an agreement)
25.6%
SLIDE 4
Scope of definition of IP (e.g., Which kinds of IP are going to be considered and affected by an agreement) Your Comments
SLIDE 5
Scope of definition of IP (e.g., Which kinds of IP are going to be considered and affected by an agreement) Your Comments
SLIDE 6
Scope of definition of IP (e.g., Which kinds of IP are going to be considered and affected by an agreement) Your Comments
SLIDE 7
Disclosure requirements (e.g., disclosing inventions to the sponsor)
10.3%
SLIDE 8
Disclosure requirements (e.g., disclosing inventions to the sponsor) Your Comments
SLIDE 9
Disclosure requirements (e.g., disclosing inventions to the sponsor) Your Comments
SLIDE 10
Ownership of new IP
15.4%
SLIDE 11
Ownership of new IP Your Comments
SLIDE 12
Ownership of new IP Your Comments
SLIDE 13
Ownership of new IP Your Comments
SLIDE 14
Joint ownership of IP absent joint inventorship
17.9%
SLIDE 15
Joint ownership of IP absent joint inventorship Your Comments
SLIDE 16
Joint ownership of IP absent joint inventorship Your Comments
SLIDE 17
Patent decisions and patent costs; Costs for protection of IP
7.9%
SLIDE 18
Patent decisions and patent costs; Costs for protection of IP Your Comments
SLIDE 19
Research use of IP by funder or performer
15.8%
SLIDE 20
Research use of IP by funder or performer Your Comments
SLIDE 21
Research use of IP by funder or performer Your Comments
SLIDE 22
Research use of IP by funder or performer Your Comments
SLIDE 23
Access to background IP
18.9%
SLIDE 24
Access to background IP Your Comments
SLIDE 25
Access to background IP Your Comments
SLIDE 26
Access to background IP Your Comments
SLIDE 27
Sharing of research materials
12.8%
SLIDE 28
Control of licensing
18.4%
SLIDE 29
Control of licensing Your Comments
SLIDE 30
Control of licensing Your Comments
SLIDE 31
Control of licensing Your Comments
SLIDE 32
Disclosure of licensing efforts
16.2%
SLIDE 33
Disclosure of licensing efforts Your Comments
SLIDE 34
Royalty issues / sharing / distribution; Use of royalties for future research
56.4%
SLIDE 35
Royalty issues / sharing / distribution; Use of royalties for future research Your Comments
SLIDE 36
Royalty issues / sharing / distribution; Use of royalties for future research Your Comments
SLIDE 37
Conflicts of interest
10.3%
SLIDE 38
Conflicts of interest Your Comments
SLIDE 39
Disposition / Abandonment of patent protection
5.3%
SLIDE 40
Publication Rights (right of performers to publish research results; Right of funders to review publication for potentially patentable subject matter)
13.2%
SLIDE 41
Publication Rights (right of performers to publish research results; Right of funders to review publication for potentially patentable subject matter) Your Comments
SLIDE 42
Publication Rights (right of performers to publish research results; Right of funders to review publication for potentially patentable subject matter) Your Comments
SLIDE 43
Ownership/disposition of other research results (e.g., data, prototypes, and
- ther tangible and intangible research results)
15.8%
SLIDE 44
Ownership/disposition of other research results (e.g., data, prototypes, and
- ther tangible and intangible research results)
Your Comments
SLIDE 45
Patient access to resulting drugs, devices, diagnostics and cures including requirements to flow license terms to licensees that require: (1) reasonable effort to assure patient access, (2) reasonable efforts to establish patient assistance program, (3) mechanism to assure patient access.
21.6%
SLIDE 46
Patient access to resulting drugs, devices, diagnostics and cures including requirements to flow license terms to licensees that require: (1) reasonable effort to assure patient access, (2) reasonable efforts to establish patient assistance program, (3) mechanism to assure patient access. Your Comments
SLIDE 47
Patient access to resulting drugs, devices, diagnostics and cures including requirements to flow license terms to licensees that require: (1) reasonable effort to assure patient access, (2) reasonable efforts to establish patient assistance program, (3) mechanism to assure patient access. Your Comments
SLIDE 48
Patient access to resulting drugs, devices, diagnostics and cures including requirements to flow license terms to licensees that require: (1) reasonable effort to assure patient access, (2) reasonable efforts to establish patient assistance program, (3) mechanism to assure patient access. Your Comments
SLIDE 49
Suggest or Describe Topics Not Included in Survey Your Suggestions
SLIDE 50
Suggest or Describe Topics Not Included in Survey Your Suggestions
SLIDE 51
Suggest or Describe Topics Not Included in Survey Your Suggestions
SLIDE 52
Suggest or Describe Topics Not Included in Survey Your Suggestions
SLIDE 53
Suggest or Describe Topics Not Included in Survey Your Suggestions
SLIDE 54
Suggest or Describe Topics Not Included in Survey Your Suggestions